BBC Inside Science
- Merck and Moderna's melanoma vaccine shows significant patient outcome improvements
- Royal Society Trivedi Book Prize interviews begin with author Kit Chapman
- Penny Sarchet shares latest notable findings from scientific journals
BBC Radio 4's Inside Science examines whether the "era of the cancer vaccine" has arrived, following an announcement this week from pharmaceutical firms Merck (known as MSD in Europe) and Moderna that a personalised cancer vaccine has significantly improved outcomes for melanoma patients. Cancer cell biologist Anne Willis…